Cargando…
The work, goals, challenges, achievements, and recommendations of orphan medicinal product organizations in India: an interview-based study
BACKGROUND: Orphan medicinal products (OMPs) are intended for the diagnosis, prevention, management or treatment of rare diseases (RDs). Each RD affects only a small fraction of the population, and therefore, historically, industry hesitated to undertake relevant research and development (R&D)....
Autores principales: | Choudhury, Mohua Chakraborty, Saberwal, Gayatri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829914/ https://www.ncbi.nlm.nih.gov/pubmed/31684990 http://dx.doi.org/10.1186/s13023-019-1224-0 |
Ejemplares similares
-
The role of patient organizations in the rare disease ecosystem in India: an interview based study
por: Choudhury, Mohua Chakraborty, et al.
Publicado: (2019) -
Rare disease patients in India are rarely involved in international orphan drug trials
por: Chakraborty, Monoswi, et al.
Publicado: (2022) -
Discrepancies between FDA documents and ClinicalTrials.gov for Orphan Drug-related clinical trial data
por: Choudhury, Mohua Chakraborty, et al.
Publicado: (2022) -
In eHealth in India today, the nature of work, the challenges and the finances: an interview-based study
por: Jarosławski, Szymon, et al.
Publicado: (2014) -
Assessment of the availability of repurposed orphan drugs in India
por: Rajueni, Khujith, et al.
Publicado: (2023)